期刊文献+

抗酿酒酵母抗体在克罗恩病的研究进展 被引量:2

原文传递
导出
摘要 克罗恩病(CD)是一个原因未明的慢性炎症性肠道疾病,可使肠组织进行性不可逆性地破坏而致肠管狭窄、瘘管形成等。目前CD诊断没有统一金标准,主要依赖于临床表现、X线、结肠镜检查及活检结果等各项临床资料的综合评价。研究人员曾试图在炎症性肠病(IBD)寻找一种特异性的血清标志物,以便早期诊断和及时处理干预。当首次发现CD患者血清中ASCA表达较对照组高时,认为ASCA可作为CD的血清标志物。自此,很多学者将ASCA作为区分CD和溃疡性结肠炎(UC)的血清标志物。然而ASCA如何产生,与环境因素及遗传因素的关系如何,能否反映CD的严重程度,是否为可靠稳定的标志物?近年来研究者们一直围绕着以上的问题进行研究。
作者 何晓生 兰平
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第12期1585-1587,共3页 Chinese Journal of Experimental Surgery
  • 相关文献

参考文献3

二级参考文献43

  • 1周军,汪建平,兰平,吴小剑,黄美近,宋新明.结肠抗原特异性T细胞克隆回输治疗大鼠溃疡性结肠炎的研究[J].中华实验外科杂志,2004,21(10):1206-1208. 被引量:14
  • 2赵辉,周建中.益气活血法治疗慢性非特异性结肠炎的临床及实验研究[J].中西医结合杂志,1989,9(9):529-532. 被引量:15
  • 3[1]Elson CO,Sartor RB,Tennyson GS,Riddell RH.Experimental models of inflammatory bowel disease.Gastroenterology 1995;109:1344-1367
  • 4[2]Floch MH.Saccharomyces:is it a probiotic or a pathogen and what is the significance of an elevated anti-S.cerevisiae antibody? J Clin Gastroenterol 2003; 36:5-6
  • 5[3]Reuther GA,Rodgers DJ.AOA continuing medical education.J Am Osteopath Assoc 1992; 92:1404,1411-7
  • 6[4]Cesaro S,Chinello P,Rossi L,Zanesco L.Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii.Support Care Cancer 2000; 8:504-5
  • 7[5]Riquelme AJ,Calvo MA,Guzman AM,Depix MS,Garcia P,Perez C,Arrese M,Labarca JA.Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.J Clin Gastroenterol 2003; 36:41-43
  • 8[6]Fiore NF,Conway JH,West KW,Kleiman MB.Saccharomyces cerevisiae infections in children.Pediatr Infect Dis J 1998; 17:1177-9
  • 9[7]Candelli M,Nista EC,Nestola M,Armuzzi A,Silveri NG,Gasbarrini G,Gasbarrini A.Saccharomyces cerevisiaeassociated diarrhea in an immunocompetent patient with ulcerative colitis.J Clin Gastroenterol 2003; 36:39-40
  • 10[8]Main J,McKenzie H,Yeaman GR,Kerr MA,Robson D,Pennington CR,Parratt D.Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.BMJ 1988; 297:1105-1106

共引文献17

同被引文献53

  • 1杨军,胡新华,张强.缺氧诱导因子-1α在腹主动脉瘤中的表达及其意义[J].中华实验外科杂志,2004,21(6):702-704. 被引量:4
  • 2Amre DK, Lu SE, Costea F, et al. Utility of serological markers in pre-dicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am J Gastroenterol,2006,101:645-652.
  • 3Klebl FH, Bataille F, Bertea CR, et al. Association of perinuclear anti- neulrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn' s disease. Inflamm Bowel Dis,2003,9:302-307.
  • 4Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol,2006 ,101:2410-2422.
  • 5Spivak J, Danders C J, Vasiliauskas EA, et al. Antibodies to I2. predict clinical response to fecal diversion in Crohn' s disease. Inflamm Bowel Dis,2006,12 : 1122-1130.
  • 6Sutton CL, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in 'affected and unaffected relatives of patients with Crohn's disease. Gut,2000,46:58-63.
  • 7Kim BG, Kim YS, Kim JS, et al. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum, 2002,45 : 1062 -1069.
  • 8Sugi K, Saitoh O, Matsuse R, et al. Antineutrophil cytoplasmic anti-bodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Am J Gastroenterol, 1999, 94 : 1304-1312.
  • 9Riis L, Vind I, Vermeire S, et al. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis,2007,13:24-32.
  • 10Seibold F, Stich O, Hufnagl R, et al. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease:a family study. Scand J Gastroenterol,2001,36 : 196-201.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部